Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2016 5
2017 15
2018 19
2019 29
2020 28
2021 23
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 34620731

94 results
Results by year
Filters applied: . Clear all
Page 1
PSMA PET validates higher rates of metastatic disease for European Association of Urology Biochemical Recurrence Risk Groups: an international multicenter study.
Ferdinandus J, Fendler WP, Farolfi A, Washington S, Mohamad O, Pampaloni MH, Scott PJ, Rodnick M, Viglianti BL, Eiber M, Herrmann K, Czernin J, Armstrong WR, Calais J, Hope TA, Piert MA. Ferdinandus J, et al. J Nucl Med. 2021 Oct 7:jnumed.121.262821. doi: 10.2967/jnumed.121.262821. Online ahead of print. J Nucl Med. 2021. PMID: 34620731
Diagnostic performance and clinical impact of 68Ga-PSMA-11 imaging in early relapsed prostate cancer after radical therapy: a prospective multicenter study (IAEA-PSMA study).
Cerci JJ, Fanti S, Lobato EE, Kunikowska J, Alonso O, Medina S, Novruzov F, Lengana T, Granados C, Kumar R, Rangarajan V, Al-Ibraheem A, Hourani M, Ali NS, Ahmad A, Keidar Z, Kucuk O, Elboga U, Bogoni M, Paez D. Cerci JJ, et al. J Nucl Med. 2021 Jul 2:jnumed.120.261886. doi: 10.2967/jnumed.120.261886. Online ahead of print. J Nucl Med. 2021. PMID: 34215674
A comprehensive assessment of 68Ga-PSMA-11 PET in biochemically recurrent prostate cancer: Results from a prospective multi-center study in 2005 patients.
Abghari-Gerst M, Armstrong WR, Nguyen K, Calais J, Czernin J, Lin D, Jariwala N, Rodnick M, Hope TA, Hearn J, Montgomery JS, Alva A, Reichert ZR, Spratt DE, Johnson TD, Scott PJH, Piert M. Abghari-Gerst M, et al. J Nucl Med. 2021 Jul 29:jnumed.121.262412. doi: 10.2967/jnumed.121.262412. Online ahead of print. J Nucl Med. 2021. PMID: 34326126
68Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC): a prospective single-centre study in patients eligible for salvage therapy.
Deandreis D, Guarneri A, Ceci F, Lillaz B, Bartoncini S, Oderda M, Nicolotti DG, Pilati E, Passera R, Zitella A, Bellò M, Parise R, Carlevato R, Ricardi U, Gontero P. Deandreis D, et al. Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2804-2815. doi: 10.1007/s00259-020-04809-8. Epub 2020 Apr 20. Eur J Nucl Med Mol Imaging. 2020. PMID: 32314028
Detection of Recurrent Prostate Cancer With 18F-Fluciclovine PET/MRI.
Selnæs KM, Krüger-Stokke B, Elschot M, Johansen H, Steen PA, Langørgen S, Aksnessæther BY, Indrebø G, Sjøbakk TAE, Tessem MB, Moestue SA, Knobel H, Tandstad T, Bertilsson H, Solberg A, Bathen TF. Selnæs KM, et al. Front Oncol. 2020 Dec 23;10:582092. doi: 10.3389/fonc.2020.582092. eCollection 2020. Front Oncol. 2020. PMID: 33425735 Free PMC article.
94 results